185 related articles for article (PubMed ID: 26672897)
1. Risks of thromboembolism associated with hormonal contraceptives related to body mass index and aging in Japanese women.
Sugiura K; Kobayashi T; Ojima T
Thromb Res; 2016 Jan; 137():11-16. PubMed ID: 26672897
[TBL] [Abstract][Full Text] [Related]
2. Risks of thromboembolism associated with hormone contraceptives in Japanese compared with Western women.
Kobayashi T; Sugiura K; Ojima T
J Obstet Gynaecol Res; 2017 May; 43(5):789-797. PubMed ID: 28422361
[TBL] [Abstract][Full Text] [Related]
3. Thromboembolism as the adverse event of combined oral contraceptives in Japan.
Sugiura K; Kobayashi T; Ojima T
Thromb Res; 2015 Dec; 136(6):1110-5. PubMed ID: 26475406
[TBL] [Abstract][Full Text] [Related]
4. Combined hormonal contraceptive use among obese women and risk for cardiovascular events: A systematic review.
Horton LG; Simmons KB; Curtis KM
Contraception; 2016 Dec; 94(6):590-604. PubMed ID: 27263039
[TBL] [Abstract][Full Text] [Related]
5. The incidence and prognosis of thromboembolism associated with oral contraceptives: Age-dependent difference in Japanese population.
Sugiura K; Ojima T; Urano T; Kobayashi T
J Obstet Gynaecol Res; 2018 Sep; 44(9):1766-1772. PubMed ID: 29998477
[TBL] [Abstract][Full Text] [Related]
6. Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study.
Dinger J; Assmann A; Möhner S; Minh TD
J Fam Plann Reprod Health Care; 2010 Jul; 36(3):123-9. PubMed ID: 20659364
[TBL] [Abstract][Full Text] [Related]
7. Nonoral combined hormonal contraceptives and thromboembolism: a systematic review.
Tepper NK; Dragoman MV; Gaffield ME; Curtis KM
Contraception; 2017 Feb; 95(2):130-139. PubMed ID: 27771476
[TBL] [Abstract][Full Text] [Related]
8. Hormonal contraception and risk of venous thromboembolism: national follow-up study.
Lidegaard Ø; Løkkegaard E; Svendsen AL; Agger C
BMJ; 2009 Aug; 339():b2890. PubMed ID: 19679613
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for venous thromboembolism in women under combined oral contraceptive. The PILl Genetic RIsk Monitoring (PILGRIM) Study.
Suchon P; Al Frouh F; Henneuse A; Ibrahim M; Brunet D; Barthet MC; Aillaud MF; Venton G; Alessi MC; Trégouët DA; Morange PE
Thromb Haemost; 2016 Jan; 115(1):135-42. PubMed ID: 26290123
[TBL] [Abstract][Full Text] [Related]
10. The epidemiological characteristics of thromboembolism related to oral contraceptives in Japan: Results of a national survey.
Sugiura K; Kobayashi T; Ojima T
J Obstet Gynaecol Res; 2021 Jan; 47(1):198-207. PubMed ID: 32885566
[TBL] [Abstract][Full Text] [Related]
11. Thrombotic risks of oral contraceptives.
Rott H
Curr Opin Obstet Gynecol; 2012 Aug; 24(4):235-40. PubMed ID: 22729096
[TBL] [Abstract][Full Text] [Related]
12. Combined hormonal contraception and risk of venous thromboembolism within the first year following pregnancy. Danish nationwide historical cohort 1995-2009.
Petersen JF; Bergholt T; Nielsen AK; Paidas MJ; Løkkegaard EC
Thromb Haemost; 2014 Jul; 112(1):73-8. PubMed ID: 24499991
[TBL] [Abstract][Full Text] [Related]
13. Risk of venous thromboembolism with drospirenone in combined oral contraceptive products.
Sehovic N; Smith KP
Ann Pharmacother; 2010 May; 44(5):898-903. PubMed ID: 20371756
[TBL] [Abstract][Full Text] [Related]
14. Hormonal contraception and venous thromboembolism.
Lidegaard Ø; Milsom I; Geirsson RT; Skjeldestad FE
Acta Obstet Gynecol Scand; 2012 Jul; 91(7):769-78. PubMed ID: 22568831
[TBL] [Abstract][Full Text] [Related]
15. Venous thromboembolism in women: a specific reproductive health risk.
ESHRE Capri Workshop Group
Hum Reprod Update; 2013; 19(5):471-82. PubMed ID: 23825156
[TBL] [Abstract][Full Text] [Related]
16. Trends in the use of hormonal contraception in Estonia 2005-2019 and the risk of arterial and venous thromboembolism: a population-based study.
Kurvits K; Laius O; Uusküla M; Laanpere M
Eur J Contracept Reprod Health Care; 2021 Oct; 26(5):413-420. PubMed ID: 34160334
[TBL] [Abstract][Full Text] [Related]
17. Venous thromboembolism in women taking hormonal contraceptives.
Blanco-Molina A; Monreal M
Expert Rev Cardiovasc Ther; 2010 Feb; 8(2):211-5. PubMed ID: 20136607
[TBL] [Abstract][Full Text] [Related]
18. SOGC clinical practice guideline. No. 252, December 2010. Oral contraceptives and the risk of venous thromboembolism: an update.
Reid R;
J Obstet Gynaecol Can; 2010 Dec; 32(12):1192-1197. PubMed ID: 21176332
[TBL] [Abstract][Full Text] [Related]
19. [Hormonal contraception and risk of venous thromboembolism: When to ask for an assessment of hemostasis? Which parameters?].
Plu-Bureau G; Horellou MH; Gompel A; Conard J
Gynecol Obstet Fertil; 2008 Apr; 36(4):448-54. PubMed ID: 18424163
[TBL] [Abstract][Full Text] [Related]
20. Systemic hormonal contraception and risk of venous thromboembolism.
Heikinheimo O; Toffol E; Partonen T; But A; Latvala A; Haukka J
Acta Obstet Gynecol Scand; 2022 Aug; 101(8):846-855. PubMed ID: 35633036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
